Harvard Bioscience Inc. (HBIO) Surged 11.54% or 0.45 To Price $4.35 On Tuesday


Harvard Bioscience Inc. (HBIO) surged 11.54% or 0.45 to $4.35. It is close to 1.27 million shares traded, which is 1759.71% compare to the average total volume 72370. The market cap of HBIO is $151.73 million. The year to date change is 18.18%. The 52 week price range is from $2.25 to $4.35. Price of HBIO have changed -1.27% during last week. It have changed 21.87% over last month, 9.86% over last 3 months, 56.00% over last 6 months and 34.48% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HBIO is 3.38. It is -22.30% below current price. The 200-day Moving Averages for HBIO is 3.00. It is -31.03% below current price. The 52-week High is 4.35. The stock hits 52-week high today. The 52-week Low is 2.25. It is -48.28% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of HBIO is 9.86 on 2017-12-29. Short % to float is 1.96%. There are some statistics of HBIO. It is has market cap $151.73 million. The share outstanding is 34.88 million. The average volume is 72370. The revenue is 100.83M. It has 20.76M cash and 53.03M in debt. The gross profit is 46.53M. The percent of top 15 Institution holding is 60.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HBIO is -4.08%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HBIO is -2.79%.


Tags:

Share this post